@article{0e61bb77a1fd4dbaa51416ead8b660a5,
title = "Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis",
keywords = "Cladribine tablets, Cost, Fingolimod, Multiple sclerosis, Natalizumab, Productivity, Travelling, Cladribine tablets, Cost, Fingolimod, Multiple sclerosis, Natalizumab, Productivity, Travelling",
author = "Petri Mankinen and Tuomas Lundstr{\"o}m and Erkki Soini and Marja-Liisa Sumelahti and Juhani Ruutiainen and Ulla Niskala and Elina J{\"a}rvinen",
year = "2019",
doi = "10.1007/s12325-019-01186-z",
language = "English",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Adis",
}